Hyperbaric Oxygen Therapy (HBOT) Devices Market Size - Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Share, Forecast, 2025 -2034
Report ID: GMI3229
Download Free PDF
Authors:
Monali Tayade,
Hyperbaric Oxygen Therapy Devices Market Size
The global hyperbaric oxygen therapy (HBOT) devices market is expected to grow significantly during the years (2025-2034) due to the increasing global burden of chronic wounds, increased incidence of patients with diabetes, and increased indications for hyperbaric medicine for both therapeutic and elective surgeries. Hyperbaric oxygen therapy (HBOT), which is the provision of 100% oxygen under pressure, is gaining greater recognition as an adjunctive therapy of high priority for the treatment of numerous medical conditions, from non-healing wounds and radiation injuries to decompression sickness and various other life-threatening infections.
The increase in non-communicable diseases (NCDs), such as diabetes and cardiovascular disease, is increasing the need for effective methods for the treatment of wounds. The International Diabetes Federation (IDF) estimates that the adult population with diabetes is expected to increase from 589 million in 2024 to 853 million in 2050.
The complications of diabetes, including but not limited to diabetic foot ulcers, chronic skin lesions, and ischemic wounds, are increasing the need for HBOT devices globally. In addition to the prevalence and factors of lifestyle disorders and the aging population, the demand for HBOT devices will only increase over the forecasted period.
Not only have the aforementioned factors driven need, but advancements in technology, such as smaller hyperbaric chambers, integrated monitoring devices, and telemedicine-enabled HBOT equipment, have adapted treatment patterns. Many healthcare facilities are increasingly implementing HBOT systems as a standard of care in the treatment of chronic wounds, recovery from sports injuries, and post-surgical recovery. Nevertheless, high device installation costs, lack of sufficient reimbursement coverage, and regulatory hurdles might limit adoption in some markets.
Hyperbaric Oxygen Therapy Devices Market Trends
The hyperbaric oxygen therapy (HBOT) devices industry is witnessing some of the key trends that are driving its growth pattern. The most conspicuous of these trends is the growing geriatric population. Based on the United Nations 2023 World Social Report, the population aged 65 and over is projected at 1.6 billion by 2050, up from 761 million in 2021. Older people are at higher risk of developing conditions such as chronic ulcers, ischemic tissue damage, and osteomyelitis, for which HBOT has a tremendous therapeutic application.
Another upcoming trend is the increasing rate of radiation-induced tissue damage, particularly among cancer survivors. Though efficient, radiation therapy tends to cause adverse effects like radiation cystitis and proctitis. HBOT has proved to be effective in such conditions with its ability to enhance angiogenesis and curb inflammation. With cancer survivorship on the rise globally, the use of HBOT as a secondary treatment option is also seeing hyperbaric oxygen therapy devices market growth.
Furthermore, cosmetic and wellness clinics are starting to incorporate HBOT into their recovery plans for rejuvenation of the skin, post-laser recovery, and anti-aging. This cross-entry into the aesthetic and wellness market is diversifying the revenue streams of the market beyond the conventional healthcare environments.
The combination of HBOT with regenerative treatments, including stem cell therapy and platelet-rich plasma (PRP), is also becoming popular. HBOT improves the mobilization of stem cells and tissue repair and thus increases the treatment efficacy. Collaborations between medical device firms and academic institutions are driving innovations in next-generation chambers with real-time patient monitoring, pressure management based on artificial intelligence, and advanced safety features.
Hyperbaric Oxygen Therapy Devices Market Analysis
The monoplace HBOT devices industry is expected to lead during 2025-2034, thanks to its immense application in the hospital-based and outpatient markets. Single-patient chambers have numerous benefits such as simplicity of use, reduced operating expenses, and minimized space, which make them suitable for smaller medical facilities. Portable and mobile monoplace systems demand is particularly increasing in home healthcare and ambulatory centers, where adaptability and safety are most important.
In addition, multiplace chambers, designed to serve several patients at once, are increasingly being accepted in big hospitals, diving facilities, and military bases. They have added sophisticated features such as inbuilt intercoms and stretchers for serving critically ill patients and emergencies.
From the application point of view, the wound healing area remains to be on the top, led by the rising worldwide incidence of diabetes, peripheral artery disease, and obesity-induced complications. HBOT has a unique effectiveness in minimizing hypoxia, improving leukocyte function, and stimulating collagen synthesis in chronic wounds.
Additionally, neurological uses of HBOT, such as its application in the management of traumatic brain injuries, stroke rehabilitation, and cerebral palsy, are being investigated intensively through clinical trials. Evidence is available to imply that HBOT can benefit neurogenesis and cerebral oxygenation, thereby maximizing cognitive improvement in patients following stroke or trauma.
North America is expected to have a commanding share in the hyperbaric oxygen therapy devices market during the period from 2025 to 2034. This is due to the robust healthcare infrastructure, increasing healthcare spending, and early adoption of novel treatment methodologies in the U.S. and Canada.
The availability of prominent HBOT producers and increasing clinical research activity also contributes to regional HBOT devices market expansion. Hyperbaric medicine is also more widely utilized in outpatient centers for wound care, trauma centers, and specialized veteran hospitals in the U.S. The region is also assisted by supportive reimbursement policies, especially under Medicare, which reimburses HBOT for a well-defined set of disorders, thus making it more affordable for patients.
Europe is close on its heels, with nations like Germany, the UK, and France making investments in sophisticated wound treatment solutions. Increasing cases of radiation injuries, a growing elderly population, and easy access to trained healthcare professionals are driving Europe's demand for HBOT systems.
During the same time, the Asia Pacific region will experience the maximum growth in the forecast period. China, India, and Japan are seeing rising cases of diabetes, cancer, and surgical interventions. Government support to upgrade hospital infrastructure and enhance access to emerging medical technologies will drive the adoption of HBOT devices in this region.
Hyperbaric Oxygen Therapy Devices Market Share
The global market of HBOT devices is moderately concentrated, with several established firms at the forefront of innovation and international distribution. Leading companies in this market are:
These players are aggressively working on product innovation, strategic acquisitions, and international expansion to reinforce their market position. The inclusion of digital surveillance solutions, safety-enhancing automation, and cost-effective portable solutions is one of the domains where major players are heavily investing.
Further, partnerships with research organizations and healthcare organizations are enabling the creation of tailored treatment protocols, especially for post-COVID-19 syndrome and long-haul respiratory diseases.
Hyperbaric Oxygen Therapy Devices Industry News
In December 2024, USF Health opened the first phase of a $28 million state-funded clinical trial to test the efficacy of hyperbaric oxygen therapy, or HBOT, in treating traumatic brain injury among Florida veterans and service members. Nationally acclaimed as among the most thorough and demanding studies of its kind, this historic undertaking has the potential to profoundly impact the way HBOT is perceived as a treatment method for neurological disorders, with long-term results potentially influencing future clinical practices.
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →